Provided by Tiger Trade Technology Pte. Ltd.

FUNDX FUTURE FUND OPPORTUNITIES ETF

29.94
-0.3800-1.25%
Post-market: 29.940.00000.00%19:30 EDT
Volume:6K
Turnover:187.40K
Market Cap:239.97M
PE:- -
High:30.03
Open:30.03
Low:29.90
Close:30.32
52wk High:31.30
52wk Low:25.44
Shares:8.02M
Float Shares:8.02M
Volume Ratio:0.29
T/O Rate:0.08%
Dividend:0.49
Dividend Rate:1.65%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Guardant Health Co-CEO AmirAli Talasaz Disposes of USD 6.35 Million in Common Shares

Reuters
·
2 hours ago

Guardant Health to Appeal Delaware Court Ruling in Patent Dispute; Shares Fall

MT Newswires Live
·
4 hours ago

Guardant Health to appeal federal district court judgment in TwinStrand case

TIPRANKS
·
4 hours ago

Guardant Health, Inc.: Remains Confident That it Did not Infringe Asserted Patents

THOMSON REUTERS
·
5 hours ago

Guardant Health, - Current Guardant Reveal and Shield Products Excluded from Final Court Order

THOMSON REUTERS
·
5 hours ago

Guardant Health to Appeal Federal District Court Judgment

THOMSON REUTERS
·
5 hours ago

U.S. Court Orders Guardant to Pay $245 Million in DNA Sequencing Patent Dispute

Reuters
·
6 hours ago

Sector Update: Healthcare

MT Newswires Live
·
Yesterday

Guardant Health Loses $245.2 Million Patent Infringement Case

MT Newswires Live
·
Yesterday

Twinstrand: Court Awards Co and Uw over $245.2 Mln in Damages, Accrued Royalties & Interest for Infringement That Occurred Through May 31, 2026

THOMSON REUTERS
·
Yesterday

Twinstrand: Delaware Court Enters Judgment on Aug. 21 in Favor of Co & University of Washington in Patent Infringement Suit Against Guardant Health

THOMSON REUTERS
·
Yesterday

Twinstrand: Under Judgment, Guardant Health Must Provide Co & Uw with Quarterly Accounting of All U.S. Sales of 11 Guardant Health Products & Services

THOMSON REUTERS
·
Yesterday

Twinstrand: Court Preserves 2023 Willful Infringement Verdict & Orders 6% Royalty on Sales of 11 Guardant Health Products & Services

THOMSON REUTERS
·
Yesterday

Halozyme Director Dannielle Appelhans Files Initial Beneficial Ownership Statement

Reuters
·
Aug 22

Halozyme CEO Helen Torley Sells USD 4.13 Million in Common Shares

Reuters
·
Aug 20

Soccer-Sheffield United's Ex-Owners Winds up Company Which Bought Club

Reuters
·
Aug 19

Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,148.2

Reuters
·
Aug 19

Halozyme Appoints COUR Pharma CEO Dannielle Appelhans to Board

Reuters
·
Aug 19

Halozyme Appoints Dannielle Appelhans to Its Board of Directors

THOMSON REUTERS
·
Aug 19

Guardant Health (GH) Back In Focus As New Approvals Put Valuation To The Test

Simply Wall St.
·
Aug 18